Anastrozole

Therapeutic indications

Anastrozole is indicated for:

Hormone receptor-positive breast cancer in postmenopausal women

Women, only Adults (18 years old or older)

Anastrozole is indicated for the:

Treatment of hormone receptor-positive advanced breast cancer in postmenopausal women.
Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women.
Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 1 mg once a day

Contraindications

Active ingredient Anastrozole is contraindicated in the following cases:

Lactation

There are no data on the use of anastrozole during lactation. Anastrozole is contraindicated during breastfeeding.

Pregnancy

There are no data from the use of anastrozole in pregnant women. Studies in animals have shown reproductive toxicity. Anastrozole is contraindicated during pregnancy.

Previous: Overview

Next: Precautions